Global Lung Cancer Liquid Biops Market Research Report 2024(Status and Outlook)

Global Lung Cancer Liquid Biops Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Lung Cancer Liquid Biops Market Size was estimated at USD 194.35 million in 2023 and is projected to reach USD 426.59 million by 2029, exhibiting a CAGR of 14.00% during the forecast period.

This report provides a deep insight into the global Lung Cancer Liquid Biops market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Liquid Biops Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Liquid Biops market in any manner.

Global Lung Cancer Liquid Biops Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Biocept

EntroGen

Cynvenio Biosystems

Exosome Diagnostics

F. Hoffmann-La Roche

Clearbridge BioMedics

Bio-Rad Laboratories

Agena Bioscience

Cancer Genetics

CellMax Life

Nateras

MedGenome

OncoDNA

Genomic Health

Trovagene

Fluxion Biosciences

Biodesix

Epic Sciences

Shuwen Biotech

Personal Genome Diagnostics

Predicine

Market Segmentation (by Type)

Exosomes and RNA

CTCs and ctDNA

Market Segmentation (by Application)

Hospitals and Clinics

Physicians'Office Laboratories

Clinical Diagnostic Laboratories

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Lung Cancer Liquid Biops Market

Overview of the regional outlook of the Lung Cancer Liquid Biops Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Liquid Biops Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Lung Cancer Liquid Biops
1.2 Key Market Segments
1.2.1 Lung Cancer Liquid Biops Segment by Type
1.2.2 Lung Cancer Liquid Biops Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Lung Cancer Liquid Biops Market Overview
2.1 Global Market Overview
2.1.1 Global Lung Cancer Liquid Biops Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lung Cancer Liquid Biops Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Lung Cancer Liquid Biops Market Competitive Landscape
3.1 Global Lung Cancer Liquid Biops Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Liquid Biops Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Liquid Biops Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Liquid Biops Sales Sites, Area Served, Product Type
3.6 Lung Cancer Liquid Biops Market Competitive Situation and Trends
3.6.1 Lung Cancer Liquid Biops Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Liquid Biops Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Lung Cancer Liquid Biops Industry Chain Analysis
4.1 Lung Cancer Liquid Biops Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Lung Cancer Liquid Biops Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Lung Cancer Liquid Biops Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Liquid Biops Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Liquid Biops Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Liquid Biops Price by Type (2019-2024)
7 Lung Cancer Liquid Biops Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Liquid Biops Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Liquid Biops Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2019-2024)
8 Lung Cancer Liquid Biops Market Segmentation by Region
8.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.2 Global Lung Cancer Liquid Biops Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Liquid Biops Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Liquid Biops Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Liquid Biops Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Liquid Biops Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Liquid Biops Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biocept
9.1.1 Biocept Lung Cancer Liquid Biops Basic Information
9.1.2 Biocept Lung Cancer Liquid Biops Product Overview
9.1.3 Biocept Lung Cancer Liquid Biops Product Market Performance
9.1.4 Biocept Business Overview
9.1.5 Biocept Lung Cancer Liquid Biops SWOT Analysis
9.1.6 Biocept Recent Developments
9.2 EntroGen
9.2.1 EntroGen Lung Cancer Liquid Biops Basic Information
9.2.2 EntroGen Lung Cancer Liquid Biops Product Overview
9.2.3 EntroGen Lung Cancer Liquid Biops Product Market Performance
9.2.4 EntroGen Business Overview
9.2.5 EntroGen Lung Cancer Liquid Biops SWOT Analysis
9.2.6 EntroGen Recent Developments
9.3 Cynvenio Biosystems
9.3.1 Cynvenio Biosystems Lung Cancer Liquid Biops Basic Information
9.3.2 Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
9.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Product Market Performance
9.3.4 Cynvenio Biosystems Lung Cancer Liquid Biops SWOT Analysis
9.3.5 Cynvenio Biosystems Business Overview
9.3.6 Cynvenio Biosystems Recent Developments
9.4 Exosome Diagnostics
9.4.1 Exosome Diagnostics Lung Cancer Liquid Biops Basic Information
9.4.2 Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
9.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Product Market Performance
9.4.4 Exosome Diagnostics Business Overview
9.4.5 Exosome Diagnostics Recent Developments
9.5 F. Hoffmann-La Roche
9.5.1 F. Hoffmann-La Roche Lung Cancer Liquid Biops Basic Information
9.5.2 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
9.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Market Performance
9.5.4 F. Hoffmann-La Roche Business Overview
9.5.5 F. Hoffmann-La Roche Recent Developments
9.6 Clearbridge BioMedics
9.6.1 Clearbridge BioMedics Lung Cancer Liquid Biops Basic Information
9.6.2 Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
9.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Product Market Performance
9.6.4 Clearbridge BioMedics Business Overview
9.6.5 Clearbridge BioMedics Recent Developments
9.7 Bio-Rad Laboratories
9.7.1 Bio-Rad Laboratories Lung Cancer Liquid Biops Basic Information
9.7.2 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
9.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Market Performance
9.7.4 Bio-Rad Laboratories Business Overview
9.7.5 Bio-Rad Laboratories Recent Developments
9.8 Agena Bioscience
9.8.1 Agena Bioscience Lung Cancer Liquid Biops Basic Information
9.8.2 Agena Bioscience Lung Cancer Liquid Biops Product Overview
9.8.3 Agena Bioscience Lung Cancer Liquid Biops Product Market Performance
9.8.4 Agena Bioscience Business Overview
9.8.5 Agena Bioscience Recent Developments
9.9 Cancer Genetics
9.9.1 Cancer Genetics Lung Cancer Liquid Biops Basic Information
9.9.2 Cancer Genetics Lung Cancer Liquid Biops Product Overview
9.9.3 Cancer Genetics Lung Cancer Liquid Biops Product Market Performance
9.9.4 Cancer Genetics Business Overview
9.9.5 Cancer Genetics Recent Developments
9.10 CellMax Life
9.10.1 CellMax Life Lung Cancer Liquid Biops Basic Information
9.10.2 CellMax Life Lung Cancer Liquid Biops Product Overview
9.10.3 CellMax Life Lung Cancer Liquid Biops Product Market Performance
9.10.4 CellMax Life Business Overview
9.10.5 CellMax Life Recent Developments
9.11 Nateras
9.11.1 Nateras Lung Cancer Liquid Biops Basic Information
9.11.2 Nateras Lung Cancer Liquid Biops Product Overview
9.11.3 Nateras Lung Cancer Liquid Biops Product Market Performance
9.11.4 Nateras Business Overview
9.11.5 Nateras Recent Developments
9.12 MedGenome
9.12.1 MedGenome Lung Cancer Liquid Biops Basic Information
9.12.2 MedGenome Lung Cancer Liquid Biops Product Overview
9.12.3 MedGenome Lung Cancer Liquid Biops Product Market Performance
9.12.4 MedGenome Business Overview
9.12.5 MedGenome Recent Developments
9.13 OncoDNA
9.13.1 OncoDNA Lung Cancer Liquid Biops Basic Information
9.13.2 OncoDNA Lung Cancer Liquid Biops Product Overview
9.13.3 OncoDNA Lung Cancer Liquid Biops Product Market Performance
9.13.4 OncoDNA Business Overview
9.13.5 OncoDNA Recent Developments
9.14 Genomic Health
9.14.1 Genomic Health Lung Cancer Liquid Biops Basic Information
9.14.2 Genomic Health Lung Cancer Liquid Biops Product Overview
9.14.3 Genomic Health Lung Cancer Liquid Biops Product Market Performance
9.14.4 Genomic Health Business Overview
9.14.5 Genomic Health Recent Developments
9.15 Trovagene
9.15.1 Trovagene Lung Cancer Liquid Biops Basic Information
9.15.2 Trovagene Lung Cancer Liquid Biops Product Overview
9.15.3 Trovagene Lung Cancer Liquid Biops Product Market Performance
9.15.4 Trovagene Business Overview
9.15.5 Trovagene Recent Developments
9.16 Fluxion Biosciences
9.16.1 Fluxion Biosciences Lung Cancer Liquid Biops Basic Information
9.16.2 Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
9.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Product Market Performance
9.16.4 Fluxion Biosciences Business Overview
9.16.5 Fluxion Biosciences Recent Developments
9.17 Biodesix
9.17.1 Biodesix Lung Cancer Liquid Biops Basic Information
9.17.2 Biodesix Lung Cancer Liquid Biops Product Overview
9.17.3 Biodesix Lung Cancer Liquid Biops Product Market Performance
9.17.4 Biodesix Business Overview
9.17.5 Biodesix Recent Developments
9.18 Epic Sciences
9.18.1 Epic Sciences Lung Cancer Liquid Biops Basic Information
9.18.2 Epic Sciences Lung Cancer Liquid Biops Product Overview
9.18.3 Epic Sciences Lung Cancer Liquid Biops Product Market Performance
9.18.4 Epic Sciences Business Overview
9.18.5 Epic Sciences Recent Developments
9.19 Shuwen Biotech
9.19.1 Shuwen Biotech Lung Cancer Liquid Biops Basic Information
9.19.2 Shuwen Biotech Lung Cancer Liquid Biops Product Overview
9.19.3 Shuwen Biotech Lung Cancer Liquid Biops Product Market Performance
9.19.4 Shuwen Biotech Business Overview
9.19.5 Shuwen Biotech Recent Developments
9.20 Personal Genome Diagnostics
9.20.1 Personal Genome Diagnostics Lung Cancer Liquid Biops Basic Information
9.20.2 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
9.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Market Performance
9.20.4 Personal Genome Diagnostics Business Overview
9.20.5 Personal Genome Diagnostics Recent Developments
9.21 Predicine
9.21.1 Predicine Lung Cancer Liquid Biops Basic Information
9.21.2 Predicine Lung Cancer Liquid Biops Product Overview
9.21.3 Predicine Lung Cancer Liquid Biops Product Market Performance
9.21.4 Predicine Business Overview
9.21.5 Predicine Recent Developments
10 Lung Cancer Liquid Biops Market Forecast by Region
10.1 Global Lung Cancer Liquid Biops Market Size Forecast
10.2 Global Lung Cancer Liquid Biops Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Liquid Biops Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region
10.2.4 South America Lung Cancer Liquid Biops Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Liquid Biops by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Lung Cancer Liquid Biops Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lung Cancer Liquid Biops by Type (2025-2030)
11.1.2 Global Lung Cancer Liquid Biops Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lung Cancer Liquid Biops by Type (2025-2030)
11.2 Global Lung Cancer Liquid Biops Market Forecast by Application (2025-2030)
11.2.1 Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application
11.2.2 Global Lung Cancer Liquid Biops Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings